A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)
Clinical trial NCT02842827 · COMPLETED
Trial details
- NCT number
- NCT02842827
- Sponsor
- Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-06
- Primary completion
- 2018-10-30
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.